31 January 2020
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Richard Keen at Spire include:
Osteoporosis. Pagets disease, bone disorders, calcium metabolism
Richard Keen graduated from St Mary’s Hospital, London, UK in 1988. After general medical posts in London and Sheffield he started professional training in rheumatology, and during this time developed his specialist interest in osteoporosis. As a research fellow at St. Thomas’ Hospital, London, Richard studied the genetic regulation of postmenopausal osteoporosis, and was awarded Young Investigator awards by the American Society of Bone and Mineral Research (ASBMR) and the European Calcified Tissue Society (ECTS).
Richard Keen is now Director of the Metabolic Bone Disease Unit at the Royal National Orthopaedic Hospital, Stanmore, UK. He also holds a senior lecturer appointment at the Institute of Orthopaedics and Musculoskeletal Science, University College London, London. He heads a clinical research team, and is currently an investigator on several research studies evaluating new treatments for osteoporosis, fracture healing and other metabolic bone disorders. He is the chief investigator for the ZODIAC Study, which is assessing the role for bisphosphonates in the management of bone loss following spinal cord injury. He also heads the VIDEO Study, an arc funded clinical trial examining the effect of vitamin D supplementation on symptomatic knee osteoarthritis.
Richard is married with three children. He is a keen sportsman, with his loves being cricket and rugby. He is a qualified mini/youth rugby coach, and his winter weekends are often spent running around on a wet pitch somewhere in northwest London.Back to top
|Telephone||020 8901 5555|
|Private secretary||Jackie Barber|
|Private secretary telephone||07432 028 009|
|Private secretary firstname.lastname@example.org|
21 October 2019
Read our latest Q and A with ENT Consultant, Mr Jonathn Hughes on head and neck cancer.